Literature DB >> 9355261

Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella spp.

P C Baldi1, M M Wanke, M E Loza, N Monachesi, C A Fossati.   

Abstract

An antigenic capture ELISA was developed to measure serum antibodies against an 18 kDa cytoplasmic protein of Brucella. This assay was used to detect anti-18 kDa reactivity in sera from 30 dogs having confirmed or suspected brucellosis. Antibodies against the 18 kDa protein were found in 26 of them, which were also positive by the slide agglutination test (2ME-RSAT). The overall correlation (positive and negative results) between the ELISA and 2ME-RSAT tests was 93.3%. Additionally, these sera were assayed by an indirect ELISA using a whole extract of cytoplasmic proteins of B. abortus (LPS-free CYT). The results of both ELISAs were coincident in 28 of 30 (93.3%) dogs having confirmed or suspected brucellosis. When a serological follow-up was performed on some dogs having confirmed brucellosis, antibody titers measured by both ELISAs showed a parallel progression. On the other hand, the capture ELISA showed good specificity, since a positive result was obtained only in 2 of 103 sera from healthy dogs. These preliminary results show that the ELISA for detecting serum antibodies against the 18 kDa cytoplasmic protein of Brucella could be useful for the diagnosis of canine brucellosis. This study also shows that the results obtained with this single protein of Brucella are equivalent to those obtained with the whole extract of cytoplasmic proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355261     DOI: 10.1016/s0378-1135(97)00134-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

Review 1.  Brucella canis: An update on research and clinical management.

Authors:  Kevin L Cosford
Journal:  Can Vet J       Date:  2018-01       Impact factor: 1.008

2.  Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella.

Authors:  Y Hiriart; A H Rossi; M E Biedma; A J Errea; G Moreno; D Cayet; J Rinaldi; B Blancá; J C Sirard; F Goldbaum; P Berguer; M Rumbo
Journal:  Protein Sci       Date:  2017-03-16       Impact factor: 6.725

3.  A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Carlos A Velikovsky; Juliana Cassataro; Guillermo H Giambartolomei; Fernando A Goldbaum; Silvia Estein; Raul A Bowden; Laura Bruno; Carlos A Fossati; Moisés Spitz
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis.

Authors:  Juliana Cassataro; M Victoria Delpino; Carlos A Velikovsky; Laura Bruno; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Authors:  Carlos A Velikovsky; Fernando A Goldbaum; Juliana Cassataro; Silvia Estein; Raúl A Bowden; Laura Bruno; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

6.  Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.

Authors:  Juliana Cassataro; Karina Pasquevich; Laura Bruno; Jorge C Wallach; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 7.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

8.  Diagnosis of canine brucellosis: comparison of various serologic tests and PCR.

Authors:  Juliana P S Mol; Andressa C B Guedes; Camila Eckstein; Amanda P N Quintal; Tayse D Souza; Luis A Mathias; João Paulo A Haddad; Tatiane A Paixão; Renato L Santos
Journal:  J Vet Diagn Invest       Date:  2019-11-21       Impact factor: 1.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.